Congenital Myasthenia (CM): Clinical Trials

1 no longer available. .

Follow Congenital Myasthenia (CM): new trials by email Literature Review of Congenital Myasthenia (CM) trials Research Report on Congenital Myasthenia (CM)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome (LEMS) and Congenital Myasthenia (CM) 3,4-diaminopyridine - Lambert-Eaton Myasthenic Syndrome (LEMS), Congenital Myasthenia (CM)		No longer available	Oregon Health and Science University			2019-12-11

Narrower conditions

Lambert-Eaton Myasthenic Syndrome (1)  ·  Myasthenic Syndromes, Congenital (1)

Broader conditions

Autoimmune Diseases (1)  ·  Autoimmune Diseases of the Nervous System (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Genetic Diseases, Inborn (1)  ·  Immune System Diseases (1)  ·  Myasthenia Gravis (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Nervous System Diseases (1)  ·  Nervous System Neoplasms (1)  ·  Neurodegenerative Diseases (1)  ·  Neuromuscular Diseases (1)  ·  Neuromuscular Junction Diseases (1)  ·  Paraneoplastic Syndromes (1)  ·  Paraneoplastic Syndromes, Nervous System (1)

Interventions

Amifampridine (1)

Sponsors

Oregon Health and Science University (1)

Countries

United States (1)